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In exploratory studies aimed at elucidating CNS effects due to heavy metal toxicity, signs of 
compromised renal function were seen in rats. The studies reported here describe the sequential 
steps of the development of nephrotoxicity by trimethyltin chloride (TMT) in rats. Single doses 
of 12.25 mg/kg TMT administered orally to 150- to 175-g Long-Evans rats elicited overt signs 
of toxicity including behavioral abnormalities and marked weight loss. Concurrent with the 
development of these signs, nephrotoxicity was manifested as functional kidney compromise 
and associated histopathologic evidence oftubular damage. Pathological changes in the kidneys 
from treated rats were hyaline droplet inclusions, attenuated brush border, basolateral vacuoli- 
zation, and eosinophilic granular casts in the proximal tubule cells. These lesions were detected 
as early as 2 days post-treatment and progressed with time in an orderly and sequential fashion. 
Renal lesions between 5 and 8 days were mild to severe cortical tubular dilatation, hydropic 
degeneration, and diffuse hyaline droplet deposition in the lower nephron tubules. Medullary 
edema and exfoliation of degenerated tubular epitbelial cells with cast formation followed from 
8 to 11 days. The morphological changes were accompanied by marked elevation of blood urea 
nitrogen, parallel with polyuria at Day 2 and oliguria by Day 14. Behavioral abnormalities as 
well as weight loss correlated well with the time course and severity of renal dysfunction and 
progression of morphological changes. A second experiment compared the effects of TMT in 
rats of different weights. Heavier rats were more sensitive than lighter rats to the nephrotoxic 
effects of TMT. These effects were independent of recognizable neurotoxic effects of TMT in 
the hippocampus. 0 1987 Society of Toxicology. 
Trimethyltin (TMT) is a member of the orga- Although the neurotoxic effects of TMT 
notin class of compounds used widely in in- have been well documented, the nephrotoxic 
dustry as plasticizers of polyvinyl chloride effects of the compound have received little 
products (Evans, 1974) and as biocides incor- attention. Brown et al. (1979) reported hy- 
porated in molluscicides, insecticides, fungi- dronephrosis and vacuolar degeneration of 
cides, and bactericides (Piver, 1973). TMT renal tubules in rats administered oral doses 
induces focal pathologic lesions of the brain, of 4 mg/kg at weekly intervals. However, 
preferentially in the hippocampus and other Bouldin et al. ( 198 1) reported no effects in the 
limbic system structures (Brown et al., 1979). kidney of adult and neonatal rats adminis- 
However, in the time course of events leading tered TMT in either acute or chronic dosing 
to CNS damage, accumulated evidence indi- regimens. Brown et al. (1984) reported no ev- 
cates that early lesions also develop in the kid- idence of nephrotoxicity in marmosets re- 
ney (Robertson et al., 1984, Opacka and ceiving TMT in various dosing regimens. 
Sparrow, 1985). Preliminary studies in our laboratories indi- 
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cated that TMT increased blood urea nitro- 
gen (BUN) levels in young adult rats and pro- 
duced moderate tubular dilatation and epi- 
thelial vacuolization (Robertson et al., 1984). 
In addition, there was evidence of a parallel 
time-course relationship between the effects 
on the kidney and various behavioral mani- 
festations of TMT intoxication mimicking 
the “TMT syndrome” as described by Dyer 
et al. (1982a). Opacka and Sparrow (1985) re- 
cently documented the nephrotoxic effects 
on rats exposed to acute oral doses of 3,6, and 
10 mg/kg TMT. These effects were evident as 
early as 3 hr after dosing and were character- 
ized by marked tubular damage, increased 
urinary pH, and polyuria. 
TMT-induced neurotoxicity has been sug- 
gested as an experimental model for the study 
of various neurological deficits including epi- 
lepsy (Dyer et al., 1982b), limbic system dys- 
function (Dyer et al., 1982a), learning and 
memory disorders (Walsh et al., 1982), mini- 
mal brain dysfunction (Swartzwelder et al., 
1983), and hyperkinetic syndrome (Swartz- 
welder et al., 1983). With this increased inter- 
est in the neurotoxicity mechanisms of TMT, 
it is critical that interrelationships of TMT 
with other organs systems be investigated. 
Thus, the time course and extent of TMT-in- 
duced nephrotoxicity is essential to deter- 
mine whether this nephrotoxicity correlates 
with the development of recognizable neuro- 
toxic manifestations. Dyer et al. (1982a) 
demonstrated that heavy rats were particu- 
larly sensitive to the acute toxicity of TMT. 
In addition to the straightforward nephrotox- 
icity study, we wished to determine whether 
differences in the extent of kidney pathology 
can also be attributed to weight (possibly age) 
differences in rats. 
METHODS 
Animals and housing. Male Long-Evans rats obtained 
from Charles River Laboratories were housed in single 
sanitized cages in air-conditioned quarters. Water and 
food were offered ad libitum and the consumption of 
each was measured by differential weight every third day. 
Animals were maintained in a 12-hr photoperiod. 
Experiment I. In the first experiment, 43 adult rats 
were dosed po by single administration of 12.25 mgjkg of 
TMT chloride (K&K Laboratories) dissolved in distilled 
water. Preliminary studies determined this level to be 
equivalent to the ICday median lethal dose in this spe- 
cies, in good agreement with the level (12.6 mg/kg) deter- 
mined by Brown et al. ( 1979). TMT is a potent neurotox- 
icant with a significant vapor pressure. Handling of the 
compound, including dosing, was done in a vertical lami- 
nar flow hood or with appropriate respiratory protection. 
In addition, lab coats, double thickness latex gloves, and 
safety goggles were worn for protection of the skin and 
eyes. Fifteen rats were given distilled water and served as 
controls. All animals were observed daily for clinical 
signs of toxicity and weighed every third day. Sacrifice 
order was determined by a computerized random num- 
ber generator before the experiment was initiated. If  an 
animal died before its scheduled sacrifice, the rat with the 
next number on the list was used to replace it. Permanent 
identification numbers were assigned at sacrifice. Five 
treated animals were taken randomly at 2, 5. 8, 1 I, and 
14 days after dosing, sacrificed, and examined for gross 
pathologic and microscopic lesions. Three control ani- 
mals were sacrificed along with each treated group. Pre- 
dose weights of control and treated rats were 234 t 1.9 g 
(n = 15) and 232 f  1.2 g (n = 43), respectively. 
Urines (24 hr) were collected on Days 2, 8, and 14. 
Total volume and specific gravity of urine were deter- 
mined. Urine protein was measured semiquantitatively 
by reagent strip and quantitatively by sulfosalicylic pre- 
cipitation methods. Blood, bilirubin, glucose, and ke- 
tones were measured semiquantitatively on an auto- 
mated reagent strip reader (Clinitek). At sacrifice, ani- 
mals were anesthetized by ether inhalation and blood 
was obtained by cardiac puncture. Kidneys were exam- 
ined for gross changes, sliced, placed in 10% neutral- 
buffered formalin. and processed for paraffin embedding. 
Sections were cut and stained with PAS and hematoxy- 
lin-eosin. Frozen sections were stained with oil red-0 for 
evaluation of fat deposition. For the purpose of evaluat- 
ing nuclear density changes attributable to cell loss or ne- 
crosis, the cortex and medulla of kidneys were evaluated 
quantitatively with a semiautomated procedure using 
Feulgen-stained sections according to a method de- 
scribed elsewhere (Weinberg et al., 1987). 
Serum BUN levels were determined using the colori- 
metric urease technique (Behring Diagnostics) in a Roto- 
Chem clinical chemistry unit. Creatinine levels were de- 
termined using a sodium picrate calorimetric technique 
(Worthington) in the same unit. 
Experiment II. Three groups of six rats each in three 
different weight classes were used: heavy (450 to 525 g)-, 
medium (300 to 400 g)-, and light-weight rats (150 to 250 
g). Three rats in each group were dosed orally with 3 mgl 
kg TMT for 3 consecutive days. The remaining three rats 
were given water and served as controls. 
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FIG. 1. Weight changes in relation to time after TMT 
administration. Each bar represents the mean weight of 
surviving animals in each group; treated animals re- 
ceivedasingledoseof 12.25 mg/kg. Nforeach time point 
is as follows (control/treated): Day 2 (15/43), Day 5 (12/ 
38). Day 8 (9/26), Day 11 (6/13), and Day 14 (3/7). 
Animals were observed and weighed daily. Moribund 
animals were bled by orbital puncture for blood bio- 
chemical determinations and then sacrificed. The surviv- 
ing animals were sacrificed 14 days after dosing. At sacri- 
fice rats were anesthetized with ether and perfused 
through the heart with ice-cold physiological saline for 3 
min followed by ice-cold 10% neutral-buffered formalin 
for 10 min with the descending aorta clamped to prevent 
perfusion of the kidneys. Brain and kidneys were further 
fixed in 10% formalin overnight and processed for par- 
affin embedding. Kidney sections were stained with the 
PAS-hematoxylin-eosin and brain sections with iron- 
hematoxylin. BUN levels were determined as described 
above. 
Numerical data for blood BUN levels and animal 
weights after TMT treatment were expressed as percent- 
age of control values and as the means ? SE of the means, 
respectively. Student’s two-tailed t test was used to estab- 
lish differences between group means with p < 0.05 as 
the significance level. 
RESULTS 
Experiment I. Of 43 treated animals in this 
experiment, 8 animals were found dead and 
8 animals were sacrificed in moribund condi- 
tion. Of these 16 animals, 7 died within 8 
days postdose. The first dead animal was 
found 5 days after dosing and the last one on 
Day 13. The time course and extent of weight 
loss are indicated in Fig. 1. Treated animals 
showed significant decreases in body weight 
as compared with control animals at every 
time point. After initial weight loss, no weight 
gains were observed in treated animals on 
Days 2 and 5. On Day 8, 15% (4 of 26) of all 
treated animals gained weight as compared 
with the previous weighing. On Day 11, 38% 
(5 of 13) of treated animals and, on Day 14, 
58% (4 of 7) had weight gains. The mean 
weight of treated animals on Day 14 was 
higher than on Day 11. 
During the experiment, food consumption 
was significantly decreased compared with 
that of control animals, with control animals 
consuming an average of 22.6 g/day and 
treated animals consuming an average of 
12.5 g/day. Water consumption was not sig- 
nificantly different between control and 
treated animals, 35.4 and 34.9 ml/day, re- 
spectively. 
Marked behavioral changes were observed 
in treated animals. The first sign noted was 
persistent head tremors which gradually pro- 
gressed to generalized body tremors. Animals 
were hyperactive and hyperreactive upon 
handling and occasional spontaneous motor 
seizures were observed. Preceding death, ani- 
mals became ataxic, with eventual prostra- 
tion and stupor. Onset of tremors was as early 
as 24 hr after dose in 2 of 43 animals. Maxi- 
mal behavioral changes were evident on Days 
5-8 with 95% of surviving animals exhibiting 
behavioral abnormalities. Of 43 animals, 10 
had spontaneous motor seizures with the first 
occurrence 4 days after dosing and occur- 
rences still evident up to 11 days after dosing. 
Behavioral abnormalities gradually subsided 
in severity and frequency after 9 days. 
Urine volumes (24 hr) were significantly 
increased for treated animals on Day 2 (Table 
1). However, specific gravity was not de- 
creased. Total urine protein excretion in 24- 
hr samples was significantly elevated on Day 
2. On Day 14, urine volume was significantly 
decreased as was total urine protein. No 
changes were seen in urine ketones or biliru- 
bin. Four animals on Day 8 and 3 animals on 
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in urine. The pH of the urine was signifi- 
cantly elevated on Day 2 (pH 8.0) as com- 
pared with pH 6.7 for controls and was above 
controls on all subsequent days. 
The time course and extent of BUN 
changes are indicated in Fig. 2. BUN levels 
were progressively increased during the 
course of the study, reaching a group mean of 
80 mg/dl by Day 14. On each of Days 8, 11, 
and 14,2 of 5 treated animals had BUN levels 
under 29 mg/dl while the remaining animals 
had higher BUN levels. Rats with lower BUN 
levels invariably showed weight gain. When 
the data of all animals that gained weight (re- 
covery data in Fig. 2) were separated from 
those of animals which did not gain weight, 
all BUN increases in nonrecovering animals 
were statistically significant at Days 8, 11, and 
14. Moribund animals were followed closely 
and, when treated as a group, had a mean 
BUN level of 150 mg/dl with values ranging 
from 7 1 to 243 mg/dl. 
Creatinine levels were moderately in- 
creased; however, statistical significance was 
not established. The highest creatinine level 
observed was 1.4 mg/dl with four treated ani- 
mals having levels over 1 mg/dl. 
Upon gross pathological examination, kid- 
neys from moribund animals were pale or 
mottled. No gross changes were seen in other 
sacrificed animals. Figure 3a illustrates the 
earliest pathologic changes in proximal tu- 
bules observed 2 days after dosing, including 
the cortical area (Fig. 3b). The proximal tu- 
bules in the inner cortex were dilated with at- 
tenuated brush borders and often contained 
light eosinophilic casts in the lumina (Fig. 
3~). PAS-positive hyalin droplets were seen in 
the cytoplasm of proximal convoluted tu- 
bules and collecting ducts. Hyalin droplets 
were later observed in the pars recta of the 
tubules, in collecting ducts, in the thin loop 
of Henle, and in the pelvic urothelium. The 
straight tubules of the pars recta showed 
diffuse hydropic degeneration with pyknotic 
nuclei in addition to hyalin droplets as early 
as Day 5 (Figs. 3d,e). Many mitotic figures 
were seen in the straight tubules and occa- 
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FIG. 2. Effects ofTMT on blood BUN levels after TMT 
treatment. Each bar represents the mean BUN levels ex- 
pressed as percentage of control values (average of three 
values) at each postdose interval. BUN (recovery) indi- 
cates the mean BUN level obtained for treated animals 
that gained weight on a given day. MOR = moribund 
animals (n = 8). compared with Day 14 control values 
but not analyzed statistically. The number above each 
bar indicates n for that measurement. 
sionally in the collecting ducts in the inner 
medulla (Fig. 3f). The morphometric evalua- 
tion of the kidneys showed no consistent pat- 
tern of cellular density change following 
TMT treatment (Table 1). 
Kidneys of rats sacrificed on Day 8 and 
thereafter showed increased hyalin droplet 
inclusions in the straight tubules, collecting 
ducts, and thin loop of Henle as well as in in- 
terstitial macrophages (Fig. 4a). The epithe- 
lial lining of the collecting ducts was laden 
with hyalin droplets (Fig. 4b) and was occa- 
sionally detached from the basement mem- 
brane and exfoliated into the lumen. The tu- 
bules in the outer and inner medulla were 
diffusely edematous and partially obliterated 
the tubular lumen, encroaching upon peritu- 
bular vessels. The distal convoluted tubules 
often showed hydropic degeneration. The 
transitional epithelium at the level of the area 
of cribosa was swollen and contained numer- 
ous hyalin droplets (Fig. 4~). The severity of 
renal lesions was progressive and was most 
prominent between Days 8 and 14 (Figs. 4d- 
f). At termination several animals showed 
milder tubular lesions indicative of a recov- 
ery process, while others had persisting severe 
lesions. 
Experiment II. Two of three treated heavy 
animals were sacrificed in extremis on Days 3 
and 7, respectively, and the remaining animal 
died on Day 6. No mortality was observed in 
any other group. The pattern of weight loss is 
indicated in Fig. 5. Treated heavy animals 
lost an average of 153 g while corresponding 
control animals gained 6 g during the study. 
Intermediate-weight animals initially lost 
weight and by Day 5 had lost about 32 g. Af- 
ter Day 5, animals progressively recovered 
weight and by Day 14 averaged 11 -g gains. 
Light-weight rats did not lose weight but had 
significant decreases in weight gain as com- 
pared with control animals. 
Heavy-weight animals exhibited marked 
behavioral abnormalities within 24 hr of dos- 
ing, consisting of slight to moderate head 
tremors and progressing to generalized body 
tremors. Tail mutilation was also observed. 
Death was preceded by hyperactivity, hyper- 
reactivity, abnormal gait, ataxia, prostration, 
and stupor. No tail mutilation was seen in the 
animals of the other groups. The two treated 
rats from the heavy-weight group, sacrificed 
in extremis, had BUN levels of 140 and 180 
mg/dl. 
Pathologic changes of the kidneys from 
heavy treated rats were similar to those as de- 
scribed for animals in experiment I. Marked 
damage to the tubules in the pars recta, 
marked hyalin droplet inclusions, and many 
mitotic figures were observed in all treated 
heavy animals. Surprisingly, light- and medi- 
um-weight rats showed no evidence of kidney 
damage on Day 14. 
The hippocampus of heavy rats (all of 
which were sacrificed by Day 7) showed only 
mild cellular thinning in the dorsal pyramidal 
cell layers with no evidence of pyknosis. The 
light and medium rats (sacrificed on Day 14) 
displayed marked CA1 pyramidal cell loss. 
This loss was most pronounced in the dorsal 
(septal) hippocampus. Cellular loss was also 
evident in the CA3-4 pyramidal cell region; 
FIG. 3. (a-c) Kidney cortex of rats 2 days after single dose of 12.25 mg/kg TMT. (a) Glomeruli appear 
normal and the proximal tubules contain cytoplasmic hyaline droplets. X250. (b) Proximal tubule cells in 
the cortex with basolateral vacuolation. X400. (c) Inner cortex tubular cells have attenuated brush borders. 
Note the eosinophilic granular casts in the lumen (arrow). X250. (d-f) Cortex of rat kidney after 5 to 7 
days TMT. (d) Prominent tubular dilatation in distal tubules; proximal tubules with attenuated brush 
borders and with granular casts in the lumen. X200. (e) Tubules from pars recta with pyknotic nuclei and 
PAS-positive droplets. X200. (f) Mitotic figures (arrow) and cytoplasmic inclusions are evident in edema- 
tous tubule cells of the pars recta. X400. 
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FIG. 4. (a-f) Kidney sections from rats 8 to 14 days after TMT treatment. (a) Tubules in the pars recta 
with PAS-positive droplets; interstitial cells show inclusions (arrow). X250. (b) Collecting tubules in the 
inner medulla with inclusions (A); thin loop of Henle cells also show inclusions (arrow). X250. (c) Papillary 
ducts with narrowed lumens and lined with edematous cells (A); swollen transitional epithelium cells at 
the area cribosa (arrow). X250. (d) Atrophic distal tubular cells contain PAS-positive droplets (solid arrow); 
proximal tubular cells show cytoplasmic vacuoles (open arrows). X400. (e) Detached tubular lining epithe- 
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FIG. 5. Changes in body weight in different age-grouped animals due to TMT administration. Heavy 
grOUp: 450-525 g; medium group: 300-400 g; light group: 150-250 g. There were. three control and three 
treated rats in each weight group. P: predose weight; X: day of dose administration; *indicates death of an 
animal. Average weights (in grams) for control rats (predos&acrifice) were heavy group (503/514), me- 
dium group (344/383), and light group (189/291). 
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however, the damage was not as severe as in 
the CA 1 region. Granule cells appeared to be 
unnaffected. 
DISCUSSION 
The results of this study indicate that TMT 
is a potent nephrotoxicant in the rat, a finding 
that has been largely undetected in spite of 
recent emphasis on the study of heavy metal 
intoxications (Brown et al., 1979; Dyer et uf., 
1982a). The pathologic changes in the kidney 
with the supporting clinical laboratory data 
suggest that TMT-induced renal failure was a 
contributing factor to death or moribundity 
in treated animals. Our data are in good 
agreement with those of Opacka and Sparrow 
(1985). One exception we noted is the lack 
of change in water consumption reported in 
their study. The peak behavioral alterations 
were seen between Days 5 and 8 and coin- 
cided with the maximum extent of renal 
damage. In a preliminary study (Robertson et 
al., 1984) we established the time course of 
BUN changes in 200- to 250-g rats treated 
with 3 mg/kg TMT for 3 consecutive days. 
Peak BUN levels were found 7 days postdose 
and followed by normal values at Day 14. In 
experiment I, a higher dose was used which 
resulted in higher BUN levels leading to acute 
renal failure and death. 
The results of the urinalyses suggest that 
TMT initially induces polyuria and then an 
oliguric phase as the renal lesion progresses 
into frank acute renal failure. The polyuric 
phase was not a typical diuretic effect in that 
specific gravity did not decrease. Several ani- 
mals within the experimental group showed 
marked proteinuria, an indication of marked 
tubular damage, although these protein in- 
creases were not significant on a group basis. 
Total urine protein was increased on Day 2 
and decreased on Day 14 due to changes in 
total urine volume. The increase in pH noted 
in treated animals on Day 2 indicates an in- 
ability to acidify urine as one of the earliest 
effects of TMT. 
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One the most important clinical laboratory 
findings of this study was the marked increase 
in BUN. Water consumption was not re- 
duced in treated animals, indicating that 
BUN elevation was not due to dehydration 
but to marked renal impairment. These ele- 
vated BUN levels in moribund animals corre- 
lated with the morphological changes in the 
kidney and indicated clearly that the cause of 
morbidity was acute renal failure. The wide 
variability of BUN levels noted on Days 8, 
11, and 14 was attributed to the recovering 
animals with lower BUN levels sampled to- 
gether with rats in end-stage renal failure with 
extremely high BUN levels. 
The histogenesis of the renal lesion indi- 
cates an initial focal effect of TMT on the tu- 
bules in the outer medullary area of kidneys. 
The hyalin droplets noted in tubular epithe- 
lial cells represent the resorption of protein 
from the glomerular filtrate (Heptinstall, 
1966). The overloading of protein in the tu- 
bules and subsequent transfer into the inter- 
stitium led to the expansion of this compart- 
ment, resulting in the obstruction of vascular 
supply and swelling in the papilla. This inter- 
stitial swelling along with tubular blockage 
caused by epithelial casts may contribute to 
decreased glomerular filtration rate, oliguria, 
and uremia. There was no overt evidence of 
glomerular pathology, suggesting that in the 
pathogenesis of TMT-induced uremia in rats, 
the tubular lesions are more important than 
glomerular dysfunction. However, in-depth 
testing would be required to preclude the 
presence of glomerular dysfunction. Mori et 
al. ( 1984) observed similar tubular damage in 
guinea pigs exposed to tributyltin. The doses 
employed were higher ( 10 and 40 mg/kg/day 
for 50 days percutaneously) than those used 
in our study. Trimethyltin, however, is sub- 
stantially more hydrophilic than tributyltin, 
perhaps explaining the former compound’s 
propensity for early profound changes in the 
kidney. Furthermore, the authors saw no 
change in glomerular morphology, and cre- 
atine clearance was unaffected. These obser- 
vations are in good agreement with ours, sug- 
gesting the possibility of a common mecha- 
nism in alkyltin-induced kidney damage. 
The morphometric studies on the nuclei in 
the cortex and medulla of rats treated with 
TMT did not reveal significant density 
changes from control values. Considerable 
variation was observed in control and treated 
animals. There was a trend of increased num- 
bers of nuclei in the treated rats after 14 days, 
which may reflect hyperplasia in response to 
the loss or damage of cells as a result of TMT 
exposure. 
Histologic studies of rat renal damage sug- 
gest prompt repair and recovery from the 
nephrotoxic effects of TMT. Mitotic figures 
were frequent in tubular cells, indicative of 
an active repair process. The time course of 
the renal lesions indicates maximal severity 
at 7 to 11 days following a single oral dose of 
TMT, and the lesion is at least partially re- 
versible. 
The experimental approach used in this 
study did not allow for elucidation of the 
mechanism of TMT-induced nephrotoxicity. 
However, the morphological observations do 
suggest some possibilities. The overloading of 
hyalin droplets in tubular epithelial cells sug- 
gests that tubular dysfunction was due to al- 
tered intracellular processes of metabolism 
and transport, attributable to impaired en- 
ergy production. TMT has pronounced 
effects on oxidative phosphorylation (Al- 
dridge and Street, 197 1) which may contrib- 
ute directly to a decrease in tubular function. 
Mercuric chloride causes similar damage to 
the pars recta (McDowell et al., 1976), sug- 
gesting that this region may be exquisitely 
sensitive to metal toxicity. 
An important landmark of TMT toxicity 
is the development of significant behavioral 
alterations. The scope and extent of these be- 
havioral changes were similar to those de- 
scribed earlier as sequelae of TMT intoxica- 
tion (Brown et al., 1979; Dyer et al., 1982a). 
Many of the characteristic behavioral 
changes seen in the TMT syndrome includ- 
ing tremors, irritability, hyperreactivity, an- 
orexia, hypothermia, seizures, and stupor are 
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also seen in patients with kidney failure or 
uremia due to other causes (Schoenfeld and 
Humphreys, 1976). This suggests that many 
aspects of the TMT syndrome previously at- 
tributed to a direct neurotoxicity of the com- 
pound may actually represent secondary 
effects of kidney injury and subsequent ure- 
mic state. Essman (1960, 1965) found in- 
creased error scores in methemoglobin-in- 
duced uremic rats trained in a T maze, mea- 
sured up to 2 weeks after clinical recovery. 
The onset of behavioral changes observed in 
our study paralleled the time course of devel- 
opment of nephrotoxicity. Coincident with 
the improvement of kidney structure and 
function, there was a gradual amelioration of 
behavioral abnormalities. This might explain 
why many signs of the TMT syndrome disap- 
pear with time (Bouldin et al., 198 1; Dyer et 
al., 1982a). However, several behavioral 
deficits in rats treated with TMT persist and 
do not subside with time, including several 
central nervous system dysfunctions (Swartz- 
welder et al., 198 1; Walsh et al., 1982; Rup- 
pert et al., 1982; Johnson et al., 1984). Thus, 
this partially reversible TMT nephrotoxicity 
does not account for the persistent neuro- 
toxic manifestations. 
An important finding in the second experi- 
ment was that heavy animals had little CNS 
damage in the hippocampus pyramidal cells 
and yet exhibited marked behavioral abnor- 
malities. By contrast, light- and middle- 
weight animals did not display similarly 
marked behavioral abnormalities although 
they had pronounced loss of CA 1 pyramidal 
cells by Day 14. Therefore, the immediate be- 
havioral deficits of the TMT syndrome are 
closely correlated with the development of 
kidney damage, and were not dependent on 
overt hippocampal disruption. 
In conclusion, our studies demonstrate 
that TMT is a potent nephrotoxicant and that 
the nephrotoxicity is dose and weight (possi- 
bly age) dependent. The kidney lesion is char- 
acterized by marked morphological disrup- 
tion within the tubules, particularly in the 
pars recta and medulla, and is accompanied 
by elevated BUN levels. The time course of 
the renal lesion indicates maximal severity at 
approximately 7 to 11 days, and the lesion is 
at least partially reversible. The nephrotoxic- 
ity might be involved in the production of be- 
havioral deficits; however, the TMT-induced 
hippocampal lesion is independent of the re- 
nal lesion. 
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